Phase I/Ii Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination With Doxorubicin and Docetaxel in Breast Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-1104

Related search